Lv31
302 积分 2024-02-29 加入
Dual Mode of Action of a Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Cancer Therapy
7小时前
待确认
Role of ADCC in the in vivo antitumor effects of zalutumumab, a human anti-EGF receptor antibody
7小时前
求助中
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
3个月前
已完结
Colorectal cancer
3个月前
已完结
Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys
3个月前
已完结
New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity
4个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
4个月前
已完结
Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase
5个月前
已完结
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
6个月前
已完结
Immunoaffinity Enrichment Lc–Ms/Ms Quantitation Ofcdh17 in Tissues
6个月前
已完结
皖公网安备34019202002308
